PlainRecalls
FDA Drug Moderate Class II Terminated

TYVASO (treprostinil) Inhalation Solution Treprostinil 1.74 mg/2.9 mL (0.6 mg/mL) Tyvaso Inhalation System Starter Kit Model# TD-100/A, Rx Only, Manufactured by United Therapeutics Corporation Research Triangle Park, NC 27709, NDC# 6630220601

Reported: November 29, 2017 Initiated: September 11, 2017 #D-0083-2018

Product Description

TYVASO (treprostinil) Inhalation Solution Treprostinil 1.74 mg/2.9 mL (0.6 mg/mL) Tyvaso Inhalation System Starter Kit Model# TD-100/A, Rx Only, Manufactured by United Therapeutics Corporation Research Triangle Park, NC 27709, NDC# 6630220601

Reason for Recall

CGMP Deviations

Details

Recalling Firm
United Therapeutics Corp.
Units Affected
12 devices
Distribution
PA
Location
Durham, NC

Frequently Asked Questions

What product was recalled?
TYVASO (treprostinil) Inhalation Solution Treprostinil 1.74 mg/2.9 mL (0.6 mg/mL) Tyvaso Inhalation System Starter Kit Model# TD-100/A, Rx Only, Manufactured by United Therapeutics Corporation Research Triangle Park, NC 27709, NDC# 6630220601. Recalled by United Therapeutics Corp.. Units affected: 12 devices.
Why was this product recalled?
CGMP Deviations
Which agency issued this recall?
This recall was issued by the FDA Drug on November 29, 2017. Severity: Moderate. Recall number: D-0083-2018.